Navigation Links
'Far From Beyond': A Glimpse into the World of Biotechnology and the Future of the Free World
Date:11/25/2008

SYDNEY, Australia, Nov. 25 /PRNewswire/ -- Meet Dr. David Onslow, owner of Excellon, a biotech company based in Panacea Valley, California. Celebrate with him as he and his team of scientists rise to the top with the successes of several of their blockbuster protein drugs. Reminisce with him about a mysterious night in the 1970s when he witnessed a meteorite crash near a creek on his grandfather's farm. Stand with his wife Kate, and a team of doctors at the foot of his hospital bed wondering why such a healthy man suddenly blacked out and collapsed while on the golf course. Fight alongside his daughter, Amelia, as she struggles to survive in a world that seems "Far From Beyond."

Author Dr. Rick Ng is excited to introduce his first novel, "Far From Beyond" (published by iUniverse -- http://www.iuniverse.com), written about a time and place that could not be too far off in the future. With the advances in biotechnology and intelligence, space exploration and a truly global marketplace, the world as we know it stands at the grasp of anyone's reach. That reach may not be embraced by the right people or power, however. Global dominance is a subject of social conversation and political fear on an ongoing basis each and every day. But it only takes one day to change everything ... including the fame, fortune, and life of one biotech mogul from California:

     Glancing in the mirror as he prepared to shave, Onslow shrank back and
     dropped his razor, which clattered to the floor. The image staring back
     at him was Onslow, but not Onslow. It vaguely resembled him: the same
     boyish, unwrinkled face, and slightly tussled brown hair. But this face
     had wide-set bug eyes, a protruding forehead and a pointed-not
     square-chin. And his once brown eyes had now taken on a golden hue.

About the Author

Born in Ipoh, Malaysia, Dr. Rick Ng holds bachelor's and doctorate degrees in Chemistry from the University of Canterbury in Christchurch, New Zealand. In addition, Dr. Ng holds an MBA in International Business. Having worked in several high-profile positions within the biotech and pharmaceutical industry both in Singapore and Sydney, Dr. Ng is no stranger to the evolution of science and technology. When not authoring scientific journal articles, college textbooks or fiction novels, Dr. Ng enjoys residing in Sydney, Australia, spending time with his wife and two children. "Far From Beyond" is Dr. Ng's first novel.

"Far From Beyond" is available from: http://www.iUniverse.com, http://www.bn.com, and http://www.amazon.com

ISBN: 9780595478361 - 6 x 9 - Paperback - 224 pages - $15.95

iUniverse offers a variety of publishing services to help individuals publish, market and sell fiction, poetry and nonfiction books. The company utilizes print-on-demand technology, and is one of the largest self-publishing companies in the U.S. iUniverse is based in Bloomington, Indiana.

    Contact:

    Tom Hudock
    Personal Media Publicist
    tom.hudock@iuniverse.com
    Toll-free: 1-800-AUTHORS (288-4677) ext.5553
    Fax: 812-961-3133

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE iUniverse
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Graphene gazing gives glimpse of foundations of universe
2. Lumidigm Biometric Sensor Included in Popular Science Best of What's New for 2008 : Venus Series Fingerprint Sensor Called a Breakthrough Product by the World's Largest Science and Technology Magazine
3. Convey Computer™ Corporation Launches World's First Hybrid-Core Computer at SC08 Conference
4. It's a Bug's Life, as Flawless Photo of Wasp Wins Worldwide Olympus BioScapes Competition : Winning Sure Doesn't Sting - Olympus BioScapes 2008 Competition
5. TRIDELITY Display Solutions Partners With Two Of The World's Leading Imaging Software Companies
6. World Market for Biotechnology Reagents to Reach $32.5 Billion by 2012, According to New Report by Global Industry Analysts, Inc.
7. Cellectricon Receives Milestone Order for Cellaxess(R)HT, the Worlds First High Throughput RNAi Screening System
8. MGuard(TM), InspireMDs Novel Coronary Stent System, was Celebrated by World Leading Interventional Cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) in Washington DC, USA, October 12-17 2008
9. Unique New Initiative by World-Recognized Specialists in Heart Disease and Diabetes to Reduce Residual Vascular Risk Launched Today
10. World Gene Amplification Technologies Market to Reach $2.2 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
11. World Gene Therapy Market to Reach $484 Million by 2015, According to New Report by Global Industry Analysts, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... February 27, 2017 , ... In starting a program ... of his grandfather, “Hire for attitude. Train for skill.” , In keeping with this ... Jevohn Miller as a salesman. Zamzow is hoping to replicate the practice throughout the ...
(Date:2/25/2017)... , ... February 25, 2017 , ... ... Verified Clinical Trials in an ongoing effort to create meaningful change by ... and pharmaceutical research with emphasis on consumers and patients’ mental health well-being. , ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... Chef Jodi ... wine scene. Making stops in several cities, she gained a number of delicious ... began in Stellenbosch, a town in South Africa’s Western Cape province. It is ...
(Date:2/24/2017)... 2017 Symic Bio, a biopharmaceutical company focused ... of therapeutics, announced today the completion of enrollment for ... disease. The trial will evaluate the safety and efficacy ... reduction of restenosis following angioplasty. "We,re ... SB-030," said Nathan Bachtell , M.D., Chief Medical ...
Breaking Biology Technology:
(Date:2/7/2017)... York , February 7, 2017 ... ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or the ... and electronic transaction processing services, is pleased to announce ... the Company. Effective January 31, 2017, ... Board of Directors, CEO and President.  An experienced payment ...
(Date:2/3/2017)... -- Texas Biomedical Research Institute announced that its Board of Trustees ... the Institute,s new President and CEO. Dr. Schlesinger will take ... is currently the Chair of the Department of Microbial Infection ... Biology at Ohio State University. "We are delighted ... of Texas Biomed," said Dr. James O. Rubin , ...
(Date:2/2/2017)... JACKSONVILLE, Fla. , Feb. 2, 2017 /PRNewswire/ ... ), a clinical-stage immuno-oncology company specializing in the ... vaccines for the treatment of cancer and metastatic ... multi-gram scale-up and GMP manufacturing of a second ... T-cell vaccine targeting folate receptor alpha. The manufactured ...
Breaking Biology News(10 mins):